Back to Gastroenterology
Gastroenterologyv2013Evidence-Based

Eosinophilic Esophagitis Endoscopic Reference Score (EREFS)

Assesses severity of endoscopic findings in patients with eosinophilic esophagitis (EoE) using standardized scoring of five major endoscopic features: edema, rings, exudates, furrows, and strictures.

Clinical Input Parameters

grade
grade
grade
grade
grade
Clinical Assessment
Awaiting Parameters
erefs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Total EREFS Score = Edema (0-1) + Rings (0-3) + Exudates (0-2) + Furrows (0-1) + Strictures (0-1)

Clinical Pearls & Practice Notes

  • Score ranges from 0-9 points based on endoscopic findings
  • Higher scores indicate more severe endoscopic disease
  • Recommended to use segment with worst (highest) score
  • Should be used in conjunction with histologic assessment
  • EREFS helps standardize endoscopic assessment of EoE
  • Useful for tracking disease progression and treatment response
  • 12-21% of patients may be misclassified regarding therapeutic response
  • Normal endoscopy (score 0) does not exclude EoE diagnosis
  • Interobserver agreement is generally good for most features
  • May not capture all endoscopic abnormalities in EoE

Evidence & Literature Citations

  1. Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013 Apr;62(4):489-95. doi: 10.1136/gutjnl-2011-301817.
  2. van Rhijn BD, Verheij J, van den Bergh Weerman MA, Verseijden C, van den Wijngaard RM, de Jonge WJ, et al. The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016 Aug;44(3):300-9. doi: 10.1111/apt.13698.
  3. Dellon ES, Cotton CC, Gebhart JH, Higgins LL, Beitia R, Woosley JT, et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol. 2016 Jan;14(1):31-9. doi: 10.1016/j.cgh.2015.08.040.
  4. Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R, et al. Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis. Gastroenterology. 2016 Sep;151(3):446-57.e5. doi: 10.1053/j.gastro.2016.05.040.

Score Interpretation Ranges

No Endoscopic Features0 – 0 pts

No visible EoE features

Mild Disease1 – 2 pts

Mild endoscopic features

Moderate Disease3 – 5 pts

Moderate endoscopic features

Severe Disease6 – 9 pts

Severe endoscopic features

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.